TRDA Entrada Therapeutics, Inc.

NASDAQ
$6.80

Entrada Therapeutics, Inc. (TRDA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with TRDA's own trailing one-year pace, with 8% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
2
17 transactions
Insiders selling
5
44 transactions
Purchases
$1.6M
211,911 shares
Sales
$15.1M
1,934,700 shares
Net activity
-$13.5M
purchases less sales

How much of that selling was preplanned? 8% planned / 92% discretionary

10b5-1 plan sales $1.3M 9 transactions · 91,792 shares
Discretionary sales $13.8M 35 transactions · 1,842,908 shares

Largest single sale: $1.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: May 20, 2026 , by Zeiher Bernhardt G .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
2 fills Sell 57,674 $7.13 $411.2K 3,885,115 −1.5% of holding
2 fills Sell 385,000 $7.41 $2.9M 3,913,952 −9% of holding
2 fills Sell 77,000 $7.11 $547.5K 4,106,452 −1.8% of holding
2 fills Sell 64,526 $7.17 $462.7K 4,144,952 −1.5% of holding
2 fills Sell 50,262 $7.19 $361.4K 4,177,215 −1.2% of holding
2 fills Sell 58,176 $7.06 $410.7K 4,202,346 −1.4% of holding
2 fills Sell 88,518 $6.99 $618.7K 4,231,434 −2% of holding
2 fills Sell 7,466 $7.01 $52.3K 4,275,693 −0.2% of holding
2 fills Sell 77,844 $7.20 $560.5K 4,279,426 −1.8% of holding
2 fills Sell 29,138 $7.06 $205.7K 4,318,348 −0.7% of holding
2 fills Sell 53,044 $7.54 $400.0K 4,332,917 −1.2% of holding
2 fills Sell 43,246 $7.34 $317.4K 4,359,439 −1% of holding
PARMAR KUSH Director Sell 92,444 $7.00 $647.1K 2,691,337 −3.3% of holding
Sell 52,317 $6.85 $358.4K 2,783,781 −1.8% of holding
PARMAR KUSH Director Sell 52,317 $6.85 $358.4K 2,783,781 −1.8% of holding
Sell 10,494 $7.00 $73.5K 2,836,098 −0.4% of holding
PARMAR KUSH Director Sell 10,494 $7.00 $73.5K 2,836,098 −0.4% of holding
Sell 1,718 $6.85 $11.8K 2,846,592 −0.1% of holding
PARMAR KUSH Director Sell 1,718 $6.85 $11.8K 2,846,592 −0.1% of holding
Sell 114,756 $6.93 $795.3K 2,848,310 −3.9% of holding
PARMAR KUSH Director Sell 114,756 $6.93 $795.3K 2,848,310 −3.9% of holding
Zeiher Bernhardt G Director Buy 5,000 $5.86 $29.3K 5,000
Sethuraman Natarajan President, Research & Develop. Sell 10b5-1 25,907 $15.39 $398.8K 216,317 −10.7% of holding
Dowden Nathan J President & COO Sell 10b5-1 15,000 $15.33 $230.0K 198,588 −7% of holding
WENTWORTH KORY JAMES Chief Financial Officer Sell 10b5-1 2,500 $12.95 $32.4K 119,010 −2.1% of holding
Dowden Nathan J President & COO Sell 10b5-1 11,894 $13.05 $155.2K 198,588 −5.7% of holding
WENTWORTH KORY JAMES Chief Financial Officer Sell 10b5-1 11,388 $13.02 $148.2K 121,510 −8.6% of holding
WENTWORTH KORY JAMES Chief Financial Officer Sell 10b5-1 5,089 $13.00 $66.2K 132,898 −3.7% of holding
Dowden Nathan J President & COO Sell 10b5-1 3,116 $13.02 $40.6K 210,482 −1.5% of holding
WENTWORTH KORY JAMES Chief Financial Officer Sell 10b5-1 7,988 $12.25 $97.9K 137,987 −5.5% of holding
WENTWORTH KORY JAMES Chief Financial Officer Sell 10b5-1 8,910 $9.98 $88.9K 110,026 −7.5% of holding
4 fills Buy 28,867 $9.07 $261.8K 4,691,392
Sell 200,000 $8.80 $1.8M 2,963,066 −6.3% of holding
PARMAR KUSH Director Sell 200,000 $8.80 $1.8M 2,963,066 −6.3% of holding
4 fills Buy 100,736 $7.76 $781.6K 4,664,924
4 fills Buy 46,434 $7.50 $348.2K 4,572,549
4 fills Buy 30,874 $7.21 $222.8K 4,529,969

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.